drugset / Trial / NCT06432764
Positron Emission Tomography Study of Changes in [11C]AZ14132516 Uptake Following Administration of AZD7798 to Patients With Crohn's Disease.
NaSequentialOpen-labelTreatment
Summary
The purpose of this study is to measure the changes in intestinal uptake of radioligand \[11C\]AZ14132516 following multiple doses of AZD7798 in participants with Crohn's disease.
Timeline
- Start
- 2024-10-16
- Primary completion
- 2026-03-27
- Completion
- 2026-03-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AZD7798 | Unknown | — | — |